ArticleBMJ open2025

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China (FIRST): protocol for a prospective, multicentre registry study.

Shiyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.